TDO checkpoint inhibitor (IOmet Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTDO checkpoint inhibitor (IOmet Pharma)
Drug Alias NameTDO inhibitors (IOmet Pharma)TDO inhibitors (TPP Global Development)TDO inhibitors (IOmet Pharma/Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTryptophan 2,3-dioxygenase inhibitors
TargetsTryptophan 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIomet Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIomet Pharma Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A